Age (year) | Mean | 55.7 | Â |
 | Range | 9-95 |  |
Sex | Male | 38 | (44.7%) |
 | Female | 47 | (55.3%) |
Location | Upper extremity | 14 | (16.5%) |
 | Lower extremity | 47 | (55.3%) |
 | Trunk | 24 | (28.2%) |
Extension | Intracompartmental | 36 | (42.4%) |
 | Extracompartmental | 49 | (57.6%) |
Tumor size (mm) | Mean | 87.0 | Â |
 | Range | 20-308 |  |
Diagnosis | Bone | 19 | Â |
 | Osteosarcoma | 10 | (11.8%) |
 | Chondrosarcoma | 8 | (9.4%) |
 | Others | 1 | (1.2%) |
 | Soft tissue | 67 |  |
 | Liposarcoma | 23 | (27.1%) |
 | Undifferentiated pleomorphic sarcoma | 14 | (16.5%) |
 | Leiomyosarcoma | 7 | (8.2%) |
 | Malignant peripheral nerve sheath tumor | 5 | (5.9%) |
 | Others | 17 | (20.0%) |
Grade | High | 48 | (56.5%) |
 | Low | 37 | (43.5%) |
Surgical margin | Adequate | 74 | (87.1%) |
 | Inadequate | 11 | (12.9%) |
Follow up period (months) | Mean | 23.0 | Â |
 | Range | 6-50 |  |